These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 35044839)

  • 21. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
    Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid Cancer Survivors in the United States.
    Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
    Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk of second primary breast cancer after radioactive iodine treatment in thyroid cancer: a systematic review and meta-analysis.
    Zhang Y; Liang J; Li H; Cong H; Lin Y
    Nucl Med Commun; 2016 Feb; 37(2):110-5. PubMed ID: 26513055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Radioactive Iodine Therapy on Ovarian Function and Fertility in Female Thyroid Cancer Patients: A Systematic Review and Meta-Analysis.
    Piek MW; Postma EL; van Leeuwaarde R; de Boer JP; Bos AME; Lok C; Stokkel M; Filipe MD; van der Ploeg IMC
    Thyroid; 2021 Apr; 31(4):658-668. PubMed ID: 33012254
    [No Abstract]   [Full Text] [Related]  

  • 25. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.
    Chuang SC; Hashibe M; Yu GP; Le AD; Cao W; Hurwitz EL; Rao JY; Neugut AI; Zhang ZF
    Cancer Lett; 2006 Jul; 238(1):42-52. PubMed ID: 16039041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioactive Iodine Treatment for Children and Young Adults with Thyroid Cancer in South Korea: A Population-based Study.
    Seo GH; Kong KA; Kim BS; Kang SY; Moon BS; Yoon HJ; Kim HO
    J Clin Endocrinol Metab; 2021 Jun; 106(7):e2580-e2588. PubMed ID: 33755732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
    Silva-Vieira M; Carrilho Vaz S; Esteves S; Ferreira TC; Limbert E; Salgado L; Leite V
    Thyroid; 2017 Aug; 27(8):1068-1076. PubMed ID: 28614983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for second primary malignancies following thyroid cancer: a nationwide cohort study.
    Kim M; Kim H; Park S; Joo J; Kim IJ; Kim BH
    Eur J Endocrinol; 2022 Apr; 186(5):561-571. PubMed ID: 35286279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study.
    Taylor AJ; Croft AP; Palace AM; Winter DL; Reulen RC; Stiller CA; Stevens MC; Hawkins MM
    Int J Cancer; 2009 Nov; 125(10):2400-5. PubMed ID: 19610069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioactive Iodine-Related Clonal Hematopoiesis in Thyroid Cancer Is Common and Associated With Decreased Survival.
    Boucai L; Falcone J; Ukena J; Coombs CC; Zehir A; Ptashkin R; Berger MF; Levine RL; Fagin JA
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4216-4223. PubMed ID: 30137527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linear association between radioactive iodine dose and second primary malignancy risk in thyroid cancer.
    Kim KJ; Kim KJ; Choi J; Kim NH; Kim SG
    J Natl Cancer Inst; 2023 Jun; 115(6):695-702. PubMed ID: 36821433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Systematic Review and Meta-Analysis of Subsequent Malignant Neoplasm Risk After Radioactive Iodine Treatment of Thyroid Cancer.
    Yu CY; Saeed O; Goldberg AS; Farooq S; Fazelzad R; Goldstein DP; Tsang RW; Brierley JD; Ezzat S; Thabane L; Goldsmith CH; Sawka AM
    Thyroid; 2018 Dec; 28(12):1662-1673. PubMed ID: 30370820
    [No Abstract]   [Full Text] [Related]  

  • 33. Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015.
    Turcotte LM; Liu Q; Yasui Y; Arnold MA; Hammond S; Howell RM; Smith SA; Weathers RE; Henderson TO; Gibson TM; Leisenring W; Armstrong GT; Robison LL; Neglia JP
    JAMA; 2017 Feb; 317(8):814-824. PubMed ID: 28245323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment.
    Chow SM; Yau S; Lee SH; Leung WM; Law SC
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):992-1000. PubMed ID: 15234032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors.
    Sawka AM; Lakra DC; Lea J; Alshehri B; Tsang RW; Brierley JD; Straus S; Thabane L; Gafni A; Ezzat S; George SR; Goldstein DP
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):479-90. PubMed ID: 18284643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal Analysis of the Effect of Radioiodine Therapy on Ovarian Reserve in Females with Differentiated Thyroid Cancer.
    van Velsen EFS; Visser WE; van den Berg SAA; Kam BLR; van Ginhoven TM; Massolt ET; Peeters RP
    Thyroid; 2020 Apr; 30(4):580-587. PubMed ID: 31928168
    [No Abstract]   [Full Text] [Related]  

  • 37. Increased cancer incidence after radioiodine treatment for hyperthyroidism.
    Metso S; Auvinen A; Huhtala H; Salmi J; Oksala H; Jaatinen P
    Cancer; 2007 May; 109(10):1972-9. PubMed ID: 17393376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic.
    Qiao T; Gao D; Tong J; Shen Y; Ma J; Lv Z; Li D
    Support Care Cancer; 2022 Dec; 30(12):10169-10177. PubMed ID: 36326909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multilevel Factors Associated With More Intensive Use of Radioactive Iodine for Low-Risk Thyroid Cancer.
    Wallner LP; Banerjee M; Reyes-Gastelum D; Hamilton AS; Ward KC; Lubitz C; Hawley ST; Haymart MR
    J Clin Endocrinol Metab; 2021 May; 106(6):e2402-e2412. PubMed ID: 33687063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis.
    Lang BH; Wong KP; Cheung CY; Wan KY; Lo CY
    Ann Surg Oncol; 2013 Apr; 20(4):1329-35. PubMed ID: 23104708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.